These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33653251)

  • 1. Association of Polymorphism in Survivin Gene and the Risk of Liver Cancer Resulting from Hepatitis C Virus Among Egyptian Patients.
    Mohamed AA; Yassin AS; Gomaa BS; Darwish H; Mohamed RS; Makled S; Ramdan A; Abd-Elsalam S; Raafat MM
    Curr Cancer Drug Targets; 2021; 21(6):536-543. PubMed ID: 33653251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study.
    Li Y; Wang J; Jiang F; Lin W; Meng W
    BMC Med Genet; 2012 Jan; 13():1. PubMed ID: 22214342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
    Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
    J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
    El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
    Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
    Elsayed HM; Nabiel Y; Sheta T
    Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study.
    Ghorab RA; Fouad SH; Elsaadawy Y; Hamdy M; Taha SI
    Int J Immunopathol Pharmacol; 2024; 38():3946320241265263. PubMed ID: 38898405
    [No Abstract]   [Full Text] [Related]  

  • 10. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
    El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
    BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PRDM1 gene polymorphism in the progression of hepatocellular carcinoma in Egyptian patients.
    Mohamed AA; Esmail OE; Ibrahim AMA; Makled S; Al-Hussain E; Elsaid A; Alboraie M; El-Awady RR
    J Med Virol; 2023 Jan; 95(1):e28343. PubMed ID: 36424348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RECK Gene Promoter rs10814325 Polymorphism in Egyptian Patients with Hepatocellular Carcinoma on Top of Chronic Hepatitis C Viral Infection.
    Fakhry AB; Ahmed AI; AbdelAlim MA; Ramadan DI
    Asian Pac J Cancer Prev; 2016; 17(5):2383-8. PubMed ID: 27268601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
    Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
    J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
    Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor of Cytokine Signaling-3 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients in Egypt.
    El Sharnoby A; Bedair HM; Raia GYS; Hamed N; Sabry A; Khalaf FA; Abd Elhamed MR; Abdel-Samiee M
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4253-4261. PubMed ID: 38156861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma.
    Hsieh YS; Tsai CM; Yeh CB; Yang SF; Hsieh YH; Weng CJ
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S625-33. PubMed ID: 22052111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
    Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
    Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
    Alsalawy NF; Darwish RK; Kamal MM; ElTaweel AE; Shousha HI; Elbaz TM
    J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.